Company profile: ChemoMetec
1.1 - Company Overview
Company description
- Provider of user-friendly instruments and software for precise cell counting and viability, including NucleoCounter NC-202 and NC-200 automated cell counters, XcytoMatic 40 for cell density analysis, Via2-Cassette disposable sampling cassettes, and NC-View/NucleoView image-analysis software, serving production/R&D, GMP, quality control, clinical diagnostics, cell therapy, and large pharmaceutical applications.
Products and services
- NucleoCounter® NC-200™: An automated cell counter delivering consistent, reliable cell counting and viability measurements, frequently employed in cell-based immunotherapy manufacturing applications
- NucleoCounter® NC-202™: An automated, GMP-suitable cell counter engineered for precise cell counting and viability assessments across cell-based product manufacturing stages, delivering consistent counts and viability readouts
- XcytoMatic® 40: A high-precision instrument architected for accurate cell density analysis that minimizes human influence in cell counting, enabling consistent determination of cell concentrations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ChemoMetec
Unchained Labs
HQ: United States
Website
- Description: Provider of life science biologics tools, including platforms for protein stability, quantification, sizing, and characterization. Products include Uncle for biologics stability screening; Stunner for quantification and sizing of LNPs, proteins and aggregates; Lunatic for high-throughput protein/nucleic acid quantification; Leprechaun for lentivirus/exosome characterization; Sunshine for LNP process development; Honeybun for rapid viscosity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Unchained Labs company profile →
Biomatrica
HQ: United States
Website
- Description: Provider of biostability technologies to stabilize, process, store and ship biological samples at room temperature, preserving complex biological samples and assays based on the principles of anhydrobiosis; products include LBgard Blood Tubes for room‑temperature stabilization of blood samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomatrica company profile →
Synthego
HQ: United States
Website
- Description: Provider of genome engineering platforms enabling access to CRISPR to accelerate life science R&D, leveraging machine learning, automation, and gene editing. Offers synthetic and synthesized sgRNA/gRNA for research and therapeutic development, GMP-grade and IND-enabling sgRNA for clinical trials and pre-IND studies, and the engineered hfCas12Max nuclease for higher on-target editing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synthego company profile →
Natrix Separations
HQ: Canada
Website
- Description: Provider of high-performance single-use and multi-cycle disposable chromatography products for the life science, food, beverage and water markets, featuring technology with high binding capacity, selectivity and specificity normally associated with resin-based chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natrix Separations company profile →
iSpecimen
HQ: United States
Website
- Description: Provider of an online marketplace connecting researchers to millions of human biospecimens and patients across a global network of providers, streamlining specimen procurement. Offers diagnostic remnant, banked, and prospectively collected samples, including biofluids with associated test and clinical data, tissue with clinical/molecular annotation, stem and immune cells with donor attribute options, and matched sets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iSpecimen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ChemoMetec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ChemoMetec
2.2 - Growth funds investing in similar companies to ChemoMetec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ChemoMetec
4.2 - Public trading comparable groups for ChemoMetec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →